USA - engelsk - NLM (National Library of Medicine)

ecolab inc. - iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4) - iodine 7.5 ml in 100 ml

USA - engelsk - NLM (National Library of Medicine)

dr. reddys laboratories inc - tetrabenazine (unii: z9o08yrn8o) (tetrabenazine - unii:z9o08yrn8o) - tetrabenazine 12.5 mg - tetrabenazine tablets are indicated for the treatment of chorea associated with huntington’s disease. tetrabenazine tablets are contraindicated in patients: • who are actively suicidal, or in patients with untreated or inadequately treated depression [see warnings and precautions ( 5.1) ]. • with hepatic impairment [see use in specific populations (8.6 ), clinical pharmacology ( 12.3) ]. • taking monoamine oxidase inhibitors (maois). tetrabenazine should not be used in combination with an maoi, or within a minimum of 14 days of discontinuing therapy with an maoi [see drug interactions (7.3)]. • taking reserpine. at least 20 days should elapse after stopping reserpine before starting tetrabenazine[see drug interactions ( 7.2 )]. • taking deutetrabenazine or valbenazine [see drug interactions (7.7)]. risk summary there are no adequate data on the developmental risk associated with the use of tetrabenazine in pregnant women. administration of tetrabenazine to rats throughout pregnancy and lactation resulted in

Israel - engelsk - Ministry of Health

neopharm ltd, israel - tetrabenazine - tablets - tetrabenazine 25 mg - tetrabenazine - tetrabenazine - movement disorders, associated with organic central nervous system conditions, e.g. huntington's chorea, hemiballismus and senile chorea.moderate to severe tardive dyskinesia, which is disabling and/or socially embarrassing. the condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.

Malta - engelsk - Medicines Authority

bristol laboratories limited - carbidopa, levodopa - tablet - carbidopa 10.8 milligram(s) ; levodopa 100 milligram(s) - anti-parkinson drugs

Malta - engelsk - Medicines Authority

bristol laboratories limited - carbidopa, levodopa - tablet - carbidopa 13.5 milligram(s) ; levodopa 50 milligram(s) - anti-parkinson drugs

Malta - engelsk - Medicines Authority

bristol laboratories limited - carbidopa, levodopa - tablet - carbidopa 27 milligram(s) ; levodopa 250 milligram(s) - anti-parkinson drugs

Israel - engelsk - Ministry of Health

j-c health care ltd - haloperidol - tablets - haloperidol 5 mg - haloperidol - haloperidol - haldol is indicatedin adult patients aged 18 years and above for:• treatment of schizophrenia and schizoaffective disorder.• acute treatment of delirium when non-pharmacological treatments have failed.• treatment of moderate to severe manic episodes associated with bipolar i disorder when other treatments cannot be used.• treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar i disorder.• treatment of persistent aggression and psychotic symptoms in patients with moderate to severe alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.• treatment of tic disorders, including tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.• treatment of mild to moderate chorea in huntington’s disease, when other medicinal products are ineffective or not tolerated.in paediatric patients for:• schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.• persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated. • tic disorders, including tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.

Israel - engelsk - Ministry of Health

j-c health care ltd - haloperidol - solution (oral) - haloperidol 2 mg/ml - haloperidol - haloperidol - haldol is indicatedin adult patients aged 18 years and above for:• treatment of schizophrenia and schizoaffective disorder.• acute treatment of delirium when non-pharmacological treatments have failed.• treatment of moderate to severe manic episodes associated with bipolar i disorder when other treatments cannot be used.• treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar i disorder.• treatment of persistent aggression and psychotic symptoms in patients with moderate to severe alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.• treatment of tic disorders, including tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.• treatment of mild to moderate chorea in huntington’s disease, when other medicinal products are ineffective or not tolerated.in paediatric patients for:• schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.• persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated. • tic disorders, including tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.

Canada - engelsk - Health Canada

huntington laboratories canada ltd. - benzalkonium chloride; alkyl dimethyl ethylbenzyl ammonium chloride - aerosol - .1%; .1% - benzalkonium chloride .1%; alkyl dimethyl ethylbenzyl ammonium chloride .1% - disinfectants (for agents used on object)

Canada - engelsk - Health Canada

huntington laboratories canada ltd. - clorophene; o-phenylphenol; isopropyl alcohol; p-tert-pentylphenol - liquid - 9.12%; 5.88%; 3.03%; 2.97% - clorophene 9.12%; o-phenylphenol 5.88%; isopropyl alcohol 3.03%; p-tert-pentylphenol 2.97% - disinfectants (for agents used on object)